Social Determinants of Health Explain Disparities in Treatment-Resistant Hypertension
By Lori Solomon HealthDay Reporter
TUESDAY, May 21, 2024 -- Part of the association between race and incident apparent treatment‐resistant hypertension (aTRH) risk is mediated by social determinants of health, according to a study published online May 16 in the Journal of the American Heart Association.
Oluwasegun P. Akinyelure, from the University of Alabama at Birmingham, and colleagues examined the association of multilevel social determinants of health with incident aTRH. The analysis included data from 2,774 White and 2,257 Black U.S. adults taking antihypertensive medication participating in the Reasons for Geographic and Racial Differences in Stroke study.
The researchers found that during a median 9.5 years of follow‐up, 15.9 percent of White and 24.0 percent of Black adults developed aTRH. The excess aTRH risk among Black versus White adults was mediated by low education (14.2 percent), low income (16.0 percent), not seeing a friend or relative in the past month (8.1 percent), not having someone to care for them if ill or disabled (7.6 percent), lack of health insurance (10.6 percent), living in a disadvantaged neighborhood (18.0 percent), and living in states with poor public health infrastructure (6.0 percent).
"These findings suggest that addressing social determinants of health among adults with hypertension may reduce racial disparities in the risk of aTRH," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2024
Read this next
Lorundrostat Beneficial for BP Reduction in Uncontrolled Hypertension
WEDNESDAY, April 30, 2025 -- For patients with uncontrolled and treatment-resistant hypertension, lorundrostat is associated with greater reductions in blood pressure than...
Intensive BP Reduction Effective for Lowering All-Cause Dementia Risk
TUESDAY, April 29, 2025 -- An intensive blood pressure (BP) reduction intervention is effective for lowering the risk for all-cause dementia among individuals aged 40 years and...
Many ADHD Medications Lead to Increases in Blood Pressure and Heart Rate
MONDAY, April 21, 2025 -- Many pharmacological treatments for attention-deficit/hyperactivity disorder (ADHD) lead to increases in hemodynamic signs, including blood pressure and...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.